Testimonials

Listen to what our customers say about our technology.

Transforming cancer research through automation and scale

Dr. Akil Merchant, physician and researcher at Cedars-Sinai, is advancing cancer research in the tumor microenvironment by integrating immuno-metabolic profiling at scale. His team designed an 82-marker immuno-metabolic panel using the COMET™ platform, bringing together markers of immune function, metabolism, and cellular signaling in one assay.

In this interview, Dr. Merchant dives into:

  • How his lab’s approach balances depth and throughput;
  • The role of full automation in ensuring consistent, reproducible results;
  • Why COMET™ is uniquely suited for translational biomarker research.

Watch the full video to hear Dr. Merchant’s perspective on hyperplex spatial biology and its future impact on personalized cancer therapy.

Accelerating translational research with COMET’s streamlined marker validation

We had the opportunity to speak with Dr. Hinda Najem, a Postdoctoral Research Fellow in the Department of Neurological Surgery at Northwestern University, about how the COMET™ platform has transformed her research. Dr. Najem dedicates her work to exploring spatial proteomics techniques to better understand primary and metastatic cancers of the central nervous system and complex brain diseases. She emphasizes the critical role that cutting-edge tissue profiling technologies, like COMET™, play in advancing  translational research and achieving impactful results. 

Watch the video to discover: 

  • How Dr. Najem leverages COMET™ to enable rapid optimization of new antibodies, making it indispensable for time-sensitive projects; 
  • Why COMET™’s hyperplexing capabilities have been a game-changer in expanding her research possibilities; 
  • Why the platform stands out as the ideal choice for advancing translational research goals. 

Ultra-fast and automated hyperplexing platform for your core facility

With so many technologies to study spatial proteomics available on the market, it is hard to choose the best one for your needs. Listen to our exclusive interview with Dr. Andrew Filer, Head of the Birmingham Tissue Analytics Facility at the University of Birmingham, in which he explains why COMET™ is their go-to platform.

Play the video and discover:

  • For what purpose, Dr. Andrew Filer recommends COMET™ to other core facilities, researchers, and clinicians.
  • How COMET™ complements other technologies installed at the core facility in Birmingham.
  • How COMET™ integrates into their core facility workflow.

User-friendly spatial biology platform to study host-pathogen interactions with off-the-shelf reagents

We sat down with Dr. Matthew Pugh, MRC Clinical Research Training Fellow, Institute of Immunology and Immunotherapy, from the University of Birmingham, to discuss his experience using COMET™. Dr. Pugh developed a customized, fully automated 34-plex panel using the platform in only a few weeks to characterize immune cells and host SARS-CoV-2-infected tissues.

In this video, he explains:

  • Why is multiplex immunofluorescence crucial to study viral infections and their effects on host cells?
  • Why he would recommend COMET™ to other pathologists?
  • What advice he would give to people getting into automated staining and imaging technology?